MedTrace Logo

Clinical Trials

Showing trials with last updates posted in 2026.

NCT03595124 | ACTIVE_NOT_RECRUITING | PHASE2
15 participants

A Study to Compare Treatments for a Type of Kidney Cancer Called TFE/Translocation Renal Cell Carcinoma (tRCC)

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-27
Start Date:
2019-01-08
Completion:
2024-09-30
Conditions
  • Metastatic Renal Cell Carcinoma
  • Stage III Renal Cell Cancer AJCC v8
  • Stage IV Renal Cell Cancer AJCC v8
  • TFE3-Rearranged Renal Cell Carcinoma
  • Unresectable Renal Cell Carcinoma
Interventions
  • DRUG
  • BIOLOGICAL
Results Available
NCT03414151 | ACTIVE_NOT_RECRUITING
25 participants

Gut Microbiome in AP Naive

Study Type:
OBSERVATIONAL
Last Updated:
2026-05-27
Start Date:
2018-02-07
Completion:
2026-08-31
Conditions
  • Psychotic Disorder
  • Schizophrenia
Interventions
  • OTHER
No Results Yet
NCT03213652 | ACTIVE_NOT_RECRUITING | PHASE2
13 participants

Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-27
Start Date:
2018-04-17
Completion:
2025-09-30
Conditions
  • Advanced Malignant Solid Neoplasm
  • Malignant Solid Neoplasm
  • Recurrent Ependymoma
  • Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
  • Recurrent Hepatoblastoma
  • Recurrent Langerhans Cell Histiocytosis
  • Recurrent Malignant Germ Cell Tumor
  • Recurrent Malignant Glioma
  • Recurrent Malignant Solid Neoplasm
  • Recurrent Medulloblastoma
  • Recurrent Neuroblastoma
  • Recurrent Non-Hodgkin Lymphoma
  • Recurrent Osteosarcoma
  • Recurrent Primary Central Nervous System Neoplasm
  • Recurrent Rhabdoid Tumor
  • Recurrent Rhabdomyosarcoma
  • Recurrent Soft Tissue Sarcoma
  • Refractory Ependymoma
  • Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
  • Refractory Hepatoblastoma
  • Refractory Langerhans Cell Histiocytosis
  • Refractory Malignant Germ Cell Tumor
  • Refractory Malignant Glioma
  • Refractory Malignant Solid Neoplasm
  • Refractory Medulloblastoma
  • Refractory Neuroblastoma
  • Refractory Non-Hodgkin Lymphoma
  • Refractory Osteosarcoma
  • Refractory Primary Central Nervous System Neoplasm
  • Refractory Rhabdoid Tumor
  • Refractory Rhabdomyosarcoma
  • Refractory Soft Tissue Sarcoma
  • Wilms Tumor
Interventions
  • PROCEDURE
  • DRUG
  • OTHER
No Results Yet
NCT02867592 | ACTIVE_NOT_RECRUITING | PHASE2
109 participants

Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-27
Start Date:
2017-05-18
Completion:
2021-06-30
Conditions
  • Adrenal Cortical Carcinoma
  • Alveolar Soft Part Sarcoma
  • Central Nervous System Neoplasm
  • Childhood Clear Cell Sarcoma of Soft Tissue
  • Clear Cell Sarcoma of Soft Tissue
  • Ewing Sarcoma
  • Hepatoblastoma
  • Hepatocellular Carcinoma
  • Osteosarcoma
  • Recurrent Adrenal Cortical Carcinoma
  • Recurrent Alveolar Soft Part Sarcoma
  • Recurrent Clear Cell Sarcoma of Soft Tissue
  • Recurrent Ewing Sarcoma
  • Recurrent Hepatoblastoma
  • Recurrent Hepatocellular Carcinoma
  • Recurrent Kidney Wilms Tumor
  • Recurrent Malignant Solid Neoplasm
  • Recurrent Osteosarcoma
  • Recurrent Primary Malignant Central Nervous System Neoplasm
  • Recurrent Renal Cell Carcinoma
  • Recurrent Rhabdomyosarcoma
  • Recurrent Soft Tissue Sarcoma
  • Recurrent Thyroid Gland Medullary Carcinoma
  • Refractory Adrenal Cortical Carcinoma
  • Refractory Alveolar Soft Part Sarcoma
  • Refractory Clear Cell Sarcoma of Soft Tissue
  • Refractory Ewing Sarcoma
  • Refractory Hepatoblastoma
  • Refractory Hepatocellular Carcinoma
  • Refractory Malignant Solid Neoplasm
  • Refractory Osteosarcoma
  • Refractory Primary Central Nervous System Neoplasm
  • Refractory Primary Malignant Central Nervous System Neoplasm
  • Refractory Renal Cell Carcinoma
  • Refractory Rhabdomyosarcoma
  • Refractory Soft Tissue Sarcoma
  • Refractory Thyroid Gland Medullary Carcinoma
  • Refractory Wilms Tumor
  • Renal Cell Carcinoma
  • Rhabdomyosarcoma
  • Soft Tissue Sarcoma
  • Solid Neoplasm
  • Thyroid Gland Medullary Carcinoma
  • Wilms Tumor
Interventions
  • DRUG
  • OTHER
Results Available
NCT02568267 | ACTIVE_NOT_RECRUITING | PHASE2
534 participants

Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-27
Start Date:
2015-11-19
Completion:
2027-06-30
Conditions
  • Breast Cancer
  • Cholangiocarcinoma
  • Colorectal Cancer
  • Head and Neck Neoplasms
  • Lymphoma, Large-Cell, Anaplastic
  • Melanoma
  • Neuroendocrine Tumors
  • Non-Small Cell Lung Cancer
  • Ovarian Cancer
  • Pancreatic Cancer
  • Papillary Thyroid Cancer
  • Primary Brain Tumors
  • Renal Cell Carcinoma
  • Sarcomas
  • Salivary Gland Cancers
  • Adult Solid Tumor
Interventions
  • DRUG
No Results Yet
NCT02567435 | ACTIVE_NOT_RECRUITING | PHASE3
325 participants

Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-27
Start Date:
2016-06-01
Completion:
2023-06-30
Conditions
  • Alveolar Rhabdomyosarcoma
  • Botryoid-Type Embryonal Rhabdomyosarcoma
  • Embryonal Rhabdomyosarcoma
  • Rhabdomyosarcoma
  • Sclerosing Rhabdomyosarcoma
  • Spindle Cell Rhabdomyosarcoma
Interventions
  • DRUG
  • BIOLOGICAL
  • OTHER
  • RADIATION
Results Available
Previous
Sorted by latest updates
Next
Showing 40 trials per page